TRAQinform IQ provides clinicians with lesion-level analysis offering earlier, clearer insights into patterns of treatment response heterogeneity than traditional imaging assessments. For patients ...

Innoblative Designs, Inc. (Innoblative), a private medical device company addressing clinical unmet needs for patients with ...

-- Assignment of CPT codes marks important milestone in path to commercialization and reimbursement in U.S. -- SIRA's novel circumferential design yields reproducible ablation depths across the entire ...

The doctors’ association is blowing up the U.S.’ decades-old coding system for recording pregnancy services and starting ...

QT Imaging Holdings, Inc. (Nasdaq: QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging ...

For GI clinics and ASCs, accurate coding and documentation are critical to protecting reimbursement, reducing denials and withstanding payer audits. The list below highlights 20 high-volume procedures ...

A man used a $20/month AI tool to find illegal charges on a $195,000 hospital bill and negotiated it down to $33,000. Here’s ...

Unlocks market access and growth potential of REYOBIQ therapy in recurrent glioblastoma and pediatric brain cancer by ...

Advances reimbursement strategy in the U.S. for FemaSeed, an intended first-step infertility treatment -- ATLANTA, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical ...

Intrinsic Therapeutics has introduced the next generation of the Barricaid narrow anchor device, according to a March 4 news release. The new version of the Barricaid narrow anchor is 6mm, down from ...

The creation of a new Category III code for the FemaSeed ITI procedure reflects the innovation and differentiated approach of our technology,” said Kathy Lee-Sepsick, Chief Executive Officer and ...

Plus Therapeutics, Inc. (NASDAQ: PSTV) (the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for ...